Primary Site >> Colorectal Cancer

Gene >> FASN

  • 1997
  • 1999
  • 2000
  • 2001
  • 2004
  • 2006
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia.
PMID: 9006336
Ref: Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival.
PMID: 9191002
Ref: Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
PMID: 10632348
Ref: Synthesis and antitumor activity of an inhibitor of fatty acid synthase.
PMID: 10716717
Ref: Sterol regulatory element-binding protein-1 participates in the regulation of fatty acid synthase expression in colorectal neoplasia.
PMID: 11082286
Ref: Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53.
PMID: 11245456
Ref: [The construction of yeast two-hybrid method in the protein-interactions and its significance in hepatic metastasis of colorectal carcinoma].
PMID: 15329257
Ref: Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component.
PMID: 16118624
Ref: Overexpression of fatty acid synthase in ulcerative colitis.
PMID: 16753600
Ref: Fatty acid synthase hyperactivation in human colorectal cancer: relationship with tumor side and sex.
PMID: 17687193
Ref: Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells.
PMID: 17283163
Ref: Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
PMID: 17350669
Ref: Carnitine palmitoyltransferase I in human carcinomas: a novel role in histone deacetylation?
PMID: 18253084
Ref: Dietary soy protein inhibits DNA damage and cell survival of colon epithelial cells through attenuated expression of fatty acid synthase.
PMID: 18239060
Ref: PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations.
PMID: 18516290
Ref: Control of cell growth and survival by enzymes of the fatty acid synthesis pathway in HCT-116 colon cancer cells.
PMID: 18794082
Ref: Cohort study of fatty acid synthase expression and patient survival in colon cancer.
PMID: 18955444
Ref: Fatty acid synthase is over-expressed in large aberrant crypt foci in rats treated with azoxymethane.
PMID: 19173288
Ref: Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis.
PMID: 19186181
Ref: Increased expression of fatty acid synthase in human aberrant crypt foci: possible target for colorectal cancer prevention.
PMID: 19358283
Ref: Aurora-A expression is independently associated with chromosomal instability in colorectal cancer.
PMID: 19412426
Ref: SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer.
PMID: 19430421
Ref: High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
PMID: 19491830
Ref: A cohort study of p27 localization in colon cancer, body mass index, and patient survival.
PMID: 19505918
Ref: A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis.
PMID: 19513025
Ref: A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers.
PMID: 19686742
Ref: Interaction of molecular markers and physical activity on mortality in patients with colon cancer.
PMID: 19723652
Ref: CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.
PMID: 19790197
Ref: Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase.
PMID: 20228137
Ref: Fatty acid synthase inhibitor cerulenin suppresses liver metastasis of colon cancer in mice.
PMID: 20491775
Ref: Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors.
PMID: 20507599
Ref: The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy.
PMID: 20551061
Ref: Down-regulation of the phosphoenolpyruvate carboxykinase gene in human colon tumors and induction by omega-3 fatty acids.
PMID: 20691246
Ref: Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer.
PMID: 20808308
Ref: GREEN TEA POLYPHENOLS MEDIATED APOPTOSIS IN INTESTINAL EPITHELIAL CELLS BY A FADD-DEPENDENT PATHWAY.
PMID: 21687829
Ref: Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review.
PMID: 20473920
Ref: Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers.
PMID: 21425139
Ref: Effects of olive oil polyphenols on fatty acid synthase gene expression and activity in human colorectal cancer cells.
PMID: 21437031
Ref: Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal.
PMID: 21723078
Ref: The colorectal tumor microenvironment: the next decade.
PMID: 21735168
Ref: Serum levels of fatty acid synthase in colorectal cancer patients are associated with tumor stage.
PMID: 21727995
Ref: Low levels of lipogenic enzymes in peritumoral adipose tissue of colorectal cancer patients.
PMID: 22090062
Ref: The "HER2-PI3K/Akt-FASN Axis" regulated malignant phenotype of colorectal cancer cells.
PMID: 22218925
Ref: Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer.
PMID: 22266115
Ref: Body mass index and risk of colorectal cancer according to fatty acid synthase expression in the nurses' health study.
PMID: 22312135
Ref: SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids.
PMID: 22457791
Ref: A significant role of lipogenic enzymes in colorectal cancer.
PMID: 22753716
Ref: Fatty acid synthase regulates proliferation and migration of colorectal cancer cells via HER2-PI3K/Akt signaling pathway.
PMID: 22860766
Ref: Cytosolic malic enzyme 1 (ME1) mediates high fat diet-induced adiposity, endocrine profile, and gastrointestinal tract proliferation-associated biomarkers in male mice.
PMID: 23056418
Ref: Expression profiling of archival tumors for long-term health studies.
PMID: 23136189
Ref: The anticancer effect of oridonin is mediated by fatty acid synthase suppression in human colorectal cancer cells.
PMID: 22722903
Ref: Loss of fatty acid synthase inhibits the "HER2-PI3K/Akt axis" activity and malignant phenotype of Caco-2 cells.
PMID: 23725225
Ref: Enhanced antitumor activity of cerulenin combined with oxaliplatin in human colon cancer cells.
PMID: 23754252
Ref: Fatty acid synthase (FASN) levels in serum of colorectal cancer patients: correlation with clinical outcomes.
PMID: 24430360
Ref: Cancer cell-associated fatty acid synthase activates endothelial cells and promotes angiogenesis in colorectal cancer.
PMID: 24510238
Ref: Alpha-2-glycoprotein 1(AZGP1) regulates biological behaviors of LoVo cells by down-regulating mTOR signaling pathway and endogenous fatty acid synthesis.
PMID: 24918753
Ref: Colonic mucosal fatty acid synthase as an early biomarker for colorectal neoplasia: modulation by obesity and gender.
PMID: 25155760
Ref: Fatty acid synthase/oxidized low-density lipoprotein as metabolic oncogenes linking obesity to colon cancer via NF-kappa B in Egyptians.
PMID: 25173531
Ref: Identification of anti-metastatic drug and natural compound targets in isogenic colorectal cancer cells.
PMID: 25451013
Ref: Remodeling of phospholipid composition in colon cancer cells by 1alpha,25(OH)2D3 and its analogs.
PMID: 25625664
Ref: Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration.
PMID: 25970773
Ref: Influence of fatty acid synthase inhibitor orlistat on the DNA repair enzyme O6-methylguanine-DNA methyltransferase in human normal or malignant cells in vitro.
PMID: 26035182
Ref: L-Carnitine Ameliorates Cancer Cachexia in Mice Partly via the Carnitine Palmitoyltransferase-Associated PPAR-gamma Signaling Pathway.
PMID: 26452216
Ref: Metformin and soybean-derived bioactive molecules attenuate the expansion of stem cell-like epithelial subpopulation and confer apoptotic sensitivity in human colon cancer cells.
PMID: 26506839
Ref: Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways.
PMID: 26517691
Ref: Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway.
PMID: 26109148
Ref: Fatty acid synthase regulates invasion and metastasis of colorectal cancer via Wnt signaling pathway.
PMID: 27139420
Ref: Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis.
PMID: 28260110
Ref: Dietary glycemic and insulin scores and colorectal cancer survival by tumor molecular biomarkers.
PMID: 28268248
Ref: MACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression.
PMID: 28339092
Ref: Body mass index and risk of colorectal carcinoma subtypes classified by tumor differentiation status.
PMID: 28510098
Ref: Expression of fatty acid synthase is regulated by PGC1alpha and contributes to increased cell proliferation.
PMID: 29130104
Ref: Immunohistochemical Expression of Fatty Acid Synthase and Vascular Endothelial Growth Factor in Primary Colorectal Cancer: a Clinicopathological Study.
PMID: 29681001
Ref: Biologic Response of Colorectal Cancer Xenograft Tumors to Sequential Treatment with Panitumumab and Bevacizumab.
PMID: 29802988
Ref: Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer.
PMID: 29872506
Ref: De Novo Fatty Acid Synthesis Driven Sphingolipid Metabolism Promotes Metastatic Potential of Colorectal Cancer.
PMID: 30154249
Ref: In silico screening for identification of fatty acid synthase inhibitors and evaluation of their antiproliferative activity using human cancer cell lines.
PMID: 30256698